VAERS reports by lot

Moderna COVID-19 lot 001J212A: VAERS reports

68 VAERS reports list lot 001J212A as a Moderna COVID-19 vaccine, received between 2022-01-10 and 2023-09-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
68
Reports
26%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6125%
Neurological4318%
Cardiac / Cardiovascular3615%
Gastrointestinal2611%
Musculoskeletal198%
Respiratory188%
Dermatological (non-injection-site)135%
Allergic / Anaphylactic125%
Injection-site / Local reaction83%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated10%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida11
Puerto Rico6
Minnesota5
Oregon4
Pennsylvania4
New York3
California3
Texas3
Wisconsin3
Arkansas2
Iowa2
Missouri2

Reports by month received

2022-0124
2022-0211
2022-038
2022-045
2022-051
2022-062
2022-074
2022-082
2022-092
2022-103
2022-121
2023-011
2023-021
2023-041
2023-051
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.